Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.0151.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.17% | 37.41% | 41.64% | 30.74% | -3.29% |
| Total Depreciation and Amortization | 6.58% | 4.17% | 8.33% | 55.56% | 31.03% |
| Total Amortization of Deferred Charges | 15.48% | 18.75% | 13.75% | -- | -- |
| Total Other Non-Cash Items | -20.57% | -41.96% | -36.77% | -1.74% | 14.76% |
| Change in Net Operating Assets | 182.86% | 126.36% | -46.51% | 26.01% | 160.31% |
| Cash from Operations | 30.14% | 42.29% | 42.70% | 35.75% | 23.84% |
| Capital Expenditure | 29.03% | 77.78% | 77.42% | -- | 71.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.21% | 159.83% | 133.89% | -190.05% | 181.08% |
| Cash from Investing | 41.37% | 159.69% | 133.83% | -190.14% | 180.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,300.00% | -75.74% | -- | 10,830.83% | -99.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 98.32% | -- | -- |
| Cash from Financing | 2,300.00% | -75.74% | 89.23% | -35.69% | -99.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 222.47% | 97.96% | 107.57% | -105.47% | 113.09% |